Microscopic analysis by Montana scientists has revealed the first detailed structure of the pathogen that causes chronic ...
Trace Neuroscience, which launched this week with $101 million, benefited from last year’s approval of Qalsody. Its CEO spoke ...
Trace Neuroscience has launched in the U.S. with over $100 million in financing and a goal to develop its UNC13A-targeted treatment for ALS.
A funding boost of more than £78 million will help UCL scientists working to develop a potential treatment for motor neurone disease, for which there is currently no cure and which affects 5,000 ...
Wednesday, at the age of 69, Al Biernat died following a seven-month battle with ALS and those who worked closest to him will ...
ALS is a neurodegenerative disease that progressively paralyzes individuals as the brain loses the ability to communicate with the muscles. People living with ALS often experience a swift decline in ...
Dallas steakhouse owner Al Biernat, whose charismatic presence at his namesake restaurant attracted both the famous and the ...
California’s recent decision to create a Rare Disease Advisory Council is a milestone that brings new hope to people living ...
California’s recent decision to create a Rare Disease Advisory Council is a milestone that brings new hope to people living ...
Trace Neuroscience aims to advance an RNA-binding therapy designed to preserve — and potentially improve — muscle function in ...
Trace Neuroscience Launches with $101 Million Series A Financing to Expand Genomic Medicine for Neurodegenerative Diseases, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback